Olabisi Lab

featured publications

publications

Timothy Hopper and Opeyemi A.Olabisi. APOL1-Mediated Kidney Disease. JAMA.2024;331(19):1668-1669. doi:10.1001/jama.2024.2667. PMID: 38662391

Somenath Datta, Brett M. Antonio, Nathan H. Zahler, Jonathan W. Theile, Doug Krafte, Hengtao Zhang, Paul B. Rosenberg, Alec B. Chaves, Deborah M. Muoio, Guofang Zhang, Daniel Silas, Guojie Li, Karen Soldano, Sarah Nystrom, Davis Ferreira, Sara E. Miller, James R. Bain, Michael J. Muehlbauer, Olga Ilkayeva, Thomas C. Becker, Hans-Ewald Hohmeier, Christopher B. Newgard, and Opeyemi A.
Olabisi. APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney disease. J Clin Invest. 2024 Jan 16:e172262. Doi:10.1172/JCI172262. PMID: 38227370

Debbie S Gipson, Chia-Shi Wang, Eloise Salmon, Rasheed Gbadegesin, Abhijit Naik, Simone Sanna-Cherchi, Alessia Fornoni, Matthias Kretzler, Sandra Merschler, Paul Hoover, Kelley Kidwell, Moin Saleem, Leonardo Riella, Lawrence Holzman, Annette Jackson, Opeyemi A. Olabisi, Paolo Cravedi, Benjamin Solomon Freedman, Jonathan Himmelfarb, Marina Vivarelli, Jennifer Harder, Jon Klein, George Burke, Michelle Rheault, Cathie Spino, Hailey E. Desmond, and Howard Trachtman. FSGS Recurrence Collaboration: Report of a Symposium. Glomerular Dis. 2023 Nov 14; 4(1):1-10. Doi: 10.1159/000535138. PMID: 38348154
Opeyemi A. Olabisi. APOL1 channel blocker reduces proteinuria in FSGS. Kidney Int. 2023. doi: 10.1016/j.kint.2023.04.022. PMID: 37224918
Dinushika Mohottige, Opeyemi Olabisi and Ebony Boulware. Use of Race in Kidney Function Estimation: Lessons Learned and the Path Toward Health Justice. Annu. Rev. Med. 2023. 74:385-400. Doi:10.1146/annurev-med-042921-124419. PMID: 36706748
William C. Wester, Bryan E. Shepherd, Usman J. Wudil, Baba Maiyaki Musa, Donna J Ingles, Heather L. Prigmore, Faisal S. Dankishiya, Aima A. Ahonkhai, Bukar A. Grema, Philip J. Budge, Ayumi Takakura, Opeyemi A. Olabisi, Cheryl A. Winkler, Jeffrey B. Kopp, Joseph V. Bonventre, Christina M. Wyatt, Muktar H. Aliyu. Etiology of Persistent Microalbuminuria in Nigeria (P_MICRO study): protocol and study design. BMC Infect Dis. 2022 Jul 4; 22(1): 591.  doi: 10.1186/s12879-022-07531-y. PMID: 35787257
Sarah E. Nystrom, Guojie Li, Somenath Datta, Karen Soldano, Daniel Silas, Astrid Wein, Gentzon Hall, David Thomas and Opeyemi A. Olabisi. JAK inhibitor blocks COVID-19-cytokine-induced JAK-STAT-APOL1 axis in glomerular cells and podocytopathy in human kidney organoids. JCI Insight. 2022; 7(11); e157432. doi:10.1172/jci.insight.157432. PMID: 35472001
Sarah E. Nystrom, Guojie Li, Somenath Datta, Karen Soldano, Daniel Silas, Astrid Wein, Gentzon Hall, David Thomas and Opeyemi A. Olabisi. JAK inhibitor blocks COVID-19-cytokine-induced JAK-STAT-APOL1 axis in glomerular cells and podocytopathy in human kidney organoids. JCI Insight. 2022; 7(11); e157432. doi:10.1172/jci.insight.157432. PMID: 35472001
Olabisi OA, Nicholas SB, Norris KC. Race, Ancestry, and Genetic Risk of Kidney Failure. Am J Kidney Dis. 2022; 80(6):801-804. doi:10.1053/j.ajkd.2022.08.008. PMID: 36100174.
Olabisi OA, Freedman BI. APOL1-associated kidney disease in northern Nigerians with treated HIV infection. Kidney Int. 2021;100(1):19-21. doi:10.1016/j.kint.2021.04.023. PMID: 34154709.
Mary Baliker, Nisha Bansal, MD, MAS, Ian de Boer, MD, MS, Joseph Bonventre, MD, PhD (Co-Chair, Preclinical Science), Matthew Breyer, MD, Arlene Chapman, MD, Deidra Crews, MD, ScM, Erich Ditschman, Silvia Ferrè, PhD, Jennifer Flythe, MD, MPH, Kevin Fowler, BS, Nora Franceschini, MD, MPH, Barry Freedman, MD, Robert Friedman, Peter C. Harris, PhD, John Cijiang He, MD, PhD, Jonathan Himmelfarb, MD, Benjamin D. Humphreys, MD, PhD, Orlando M. Gutierrez, MD (Co-Chair, Clinical Science), Shuta Ishibe, MD, Joe Ix, MD, MAS, Nichole Jefferson, Bryan Kestenbaum, MD, MS, Jay Koyner, MD, Holly Kramer, MD, MPH, Precious McCowan, Ryan Murray, BA, Opeyemi Olabisi, MD, PhD, Paul Palevsky, MD, Samir M. Parikh, MD, Sharon Pearce, BA, Janos Peti-Peterdi, MD, PhD, Susan E. Quaggin, MD, Janine Reed, Glenda V. Roberts, Anne Rohall-Andrade, Sylvia Rosas, MD, MS, Mark Sarnak, MD, MS, Julie J. Scialla, MD, MHS, Steve Seliger, MD, MS, Eddie Siew, MD, MSCI, John David Spencer, MD, Katalin Susztak, MD, PhD (Co-Chair, Bench Research), Joseph Vassalotti, MD, Kerry Willis, PhD, Bessie A. Young, MD, MPH (Co-Chair, Clinical Research), and Troy Zimmerman, BA. National Kidney Foundation Research Roundtable Work Group on behalf of the National Kidney Foundation. Research Priorities for Kidney-Related Research-An Agenda to Advance Kidney Care: A Position Statement From the National Kidney Foundation. Am J Kidney Dis. 2022;79(2):141-152. doi:10.1053/j.ajkd.2021.08.018. PMID: 34627932.
Margaret DeOliveira , Colby Feeney, Caroline Leahy , Sarah Nystrom, David N. Howell, Samira S. Farouk, Ming Wu, Opeyemi A. Olabisi * , and Matthew A. Sparks # . Collapsing Glomerulopathy in Identical Twins With Lupus and High-Risk Apolipoprotein L1 (APOL1) Genotype. KI Reports. Published online June 19 2021. DOI: 10.1016/j.ekir.2021.06.005. PMID: 34514214. * Corresponding author; * Co-senior authors
Barry I. Freedman, Wylie Burke, Jasmin Divers, Lucy Eberhard, Crystal A. Gadegbeku, Rasheed Gbadegesin, Michael E. Hall, Tiffany Jones-Smith, Richard Knight, Jeffrey B. Kopp, Csaba P. Kovesdy, Keith C. Norris, Opeyemi A. Olabisi, Glenda V. Roberts, John R. Sedor and Erika Blacksher. Diagnosis, Education, and Care of Patients with APOL1-Associated Nephropathy: A Delphi Consensus and Systematic Review. JASN July 2021, 32 (7) 1765-1778. DOI:10.1681/ASN.2020101399. PMID: 33853887.
Datta S, Kataria R, Zhang JY, Moore S, Petitpas K, Mohamed A, Zahler N, Pollak MR, Olabisi OA. Kidney Disease Associated APOL1 Variants Have Dose-Dependent, Dominant Gain of Toxic Function. JASN-2020-01-0079. DOI: 10.1681/ASN.2020010079. PMID: 32675303.
Norris KC, Olabisi O, Barnettt ME, Meng YX, Martins D, Obialo C, Lee JE, Nicholas SB. The Role of Vitamin D and Oxidative Stress in Chronic Kidney Disease. Int J Environ Res Public Health. 2018 Nov 30; 15 (12). pii:E2701. DOI: 10.3390/iJerph15122701. PMID: 30513574
Olabisi OA, Heneghan JF. APOL1 Nephrotoxicity: What Does Ion Transport Have to Do with It? Semin Nephrol. 2017 Nov 17;37(6): 546-551. doi: 10.1016/j.semnephrol.2017.07.008. PMID: 29110762
Olabisi O, Al-Romaih K, Henderson J, Tomar R, Drummond I, MacRae C, Pollak M. From man to fish: What can Zebrafish tell us about ApoL1 nephropathy? Clin Nephrol. 2016 Supplement 1;86 (2016)(13):114-118. DOI: 10.5414/CNP86S116. PMID: 27509583
Olabisi OA, Zhang JY, VerPlank L, Zahler N, DiBartolo S 3rd, Heneghan JF, Schlondorff JS, Suh JH, Yan P, Alper SL, Friedman DJ, Pollak MR. APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress activated protein kinases. Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):830-7. DOI: 10.1073/pnas.1522913113. PMID: 26699492
Suk HY, Zhou C, Yang TT, Zhu H, Yu RY, Olabisi O, Yanx X, Brancho D, Kim JY, Scherer PE, Frank PG, Lisanti MP, Calvert JW, Lefer DJ, Molkentin JD, Ghigo A, Hirsch E, Jin J, Chow CW. Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterases. J Biol Chem. 2013 Feb 1;288(5):3477-88. DOI: 10.1074/jbc.M112.419150. PMID: 23258544
Olabisi OA, Chow CW. Assay for protein modification by poly-ADP-ribose in vitro. Methods Mol Biol. 2011;780:47-55. doi: 10.1007/978-1-61779-270-0_3. PMID: 21870253
Zhu H, Suk HY, Yu RY, Brancho D, Olabisi O, Yang TT, Yang X, Zhang J, Moussaif M, Durand JL, Jelicks LA, Kim JY, Scherer PE, Frank PG, Lisanti MP, Calvert JW, Duranski MR, Lefer DJ, Huston E, Baillie GS, Houslay MD, Molkentin JD, Jin J, Chow CW. Evolutionarily conserved role of calcineurin in phosphodegron-dependent degradation of phosphodiesterase 4D. Mol Cell Biol. 2010 Sep;30(18):4379-90. doi: 10.1128/MCB.01193-09. PMID: 20647544
Olabisi OA, Soto-Nieves N, Nieves E, Yang TT, Yang X, Yu RY, Suk HY, Macian F, Chow CW. Regulation of transcription factor NFAT by ADP-ribosylation. Mol Cell Biol. 2008 May;28(9):2860-71. doi: 10.1128/MCB.01746-07. PMID: 18299389
Yang TT, Suk HY, Yang X, Olabisi O, Yu RY, Durand J, Jelicks LA, Kim JY, Scherer PE, Wang Y, Feng Y, Rossetti L, Graef IA, Crabtree GR, Chow CW. Role of transcription factor NFAT in glucose and insulin homeostasis. Mol Cell Biol. 2006 Oct;26(20):7372-87. DOI: 10.1128/MCB.00580-06. PMID: 16908540
Broderick PA, Olabisi OA, Rahni DN, Zhou Y. Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies. Prog Neuropsychopharmacol Biol Psychiatry. 2004 May;28(3):547-57. DOI: 10.1016/j.pnpbp.2004.01.007. PMID: 15093963